Avecho Biotechnology Ltd (AVE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avecho Biotechnology Ltd (AVE) has a cash flow conversion efficiency ratio of -2.199x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.43 Million ≈ $-2.43 Million USD) by net assets (AU$1.56 Million ≈ $1.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Avecho Biotechnology Ltd to measure how much of total assets are equity-financed.
Avecho Biotechnology Ltd - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how Avecho Biotechnology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Avecho Biotechnology Ltd (AVE) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Avecho Biotechnology Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avecho Biotechnology Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KTIS Corporation
KO:058860
|
-0.025x |
|
Austral Gold Ltd
AU:AGD
|
0.377x |
|
New Century Logistics (BVI) Limited Ordinary Shares
NASDAQ:NCEW
|
0.782x |
|
Essen Tech Co. Ltd
KQ:043340
|
0.061x |
|
Bewhere Holdings Inc
V:BEW
|
0.009x |
|
DarioHealth Corp
NASDAQ:DRIO
|
-0.097x |
|
Primotec Group Ltd
TA:PRMG
|
0.071x |
|
Eastern Platinum Limited
TO:ELR
|
-0.033x |
Annual Cash Flow Conversion Efficiency for Avecho Biotechnology Ltd (1993–2025)
The table below shows the annual cash flow conversion efficiency of Avecho Biotechnology Ltd from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see Avecho Biotechnology Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | AU$1.56 Million ≈ $1.10 Million |
AU$1.10 Million ≈ $780.51K |
0.707x | +158.27% |
| 2024-12-31 | AU$3.27 Million ≈ $2.31 Million |
AU$-3.97 Million ≈ $-2.81 Million |
-1.214x | -143.44% |
| 2023-12-31 | AU$6.38 Million ≈ $4.51 Million |
AU$-3.18 Million ≈ $-2.25 Million |
-0.499x | +27.39% |
| 2022-12-31 | AU$2.42 Million ≈ $1.72 Million |
AU$-1.67 Million ≈ $-1.18 Million |
-0.687x | -0.54% |
| 2021-12-31 | AU$4.54 Million ≈ $3.21 Million |
AU$-3.10 Million ≈ $-2.19 Million |
-0.683x | -27.40% |
| 2020-12-31 | AU$2.65 Million ≈ $1.88 Million |
AU$-1.42 Million ≈ $-1.01 Million |
-0.536x | -314.63% |
| 2019-12-31 | AU$4.76 Million ≈ $3.37 Million |
AU$1.19 Million ≈ $841.16K |
0.250x | +144.53% |
| 2018-12-31 | AU$3.90 Million ≈ $2.76 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.561x | +44.06% |
| 2017-12-31 | AU$6.40 Million ≈ $4.53 Million |
AU$-6.42 Million ≈ $-4.54 Million |
-1.003x | -82.12% |
| 2016-12-31 | AU$11.65 Million ≈ $8.24 Million |
AU$-6.41 Million ≈ $-4.54 Million |
-0.551x | -82.97% |
| 2015-12-31 | AU$28.93 Million ≈ $20.47 Million |
AU$-8.71 Million ≈ $-6.16 Million |
-0.301x | -118.93% |
| 2014-12-31 | AU$49.03 Million ≈ $34.69 Million |
AU$-6.74 Million ≈ $-4.77 Million |
-0.137x | +34.67% |
| 2013-12-31 | AU$40.77 Million ≈ $28.85 Million |
AU$-8.58 Million ≈ $-6.07 Million |
-0.210x | -12.95% |
| 2012-12-31 | AU$62.61 Million ≈ $44.30 Million |
AU$-11.66 Million ≈ $-8.25 Million |
-0.186x | -46.22% |
| 2011-12-31 | AU$72.95 Million ≈ $51.61 Million |
AU$-9.29 Million ≈ $-6.58 Million |
-0.127x | +40.42% |
| 2010-12-31 | AU$39.01 Million ≈ $27.60 Million |
AU$-8.34 Million ≈ $-5.90 Million |
-0.214x | -19.25% |
| 2009-12-31 | AU$49.99 Million ≈ $35.37 Million |
AU$-8.96 Million ≈ $-6.34 Million |
-0.179x | -27.81% |
| 2008-12-31 | AU$51.55 Million ≈ $36.48 Million |
AU$-7.23 Million ≈ $-5.12 Million |
-0.140x | -72.82% |
| 2007-12-31 | AU$133.76 Million ≈ $94.65 Million |
AU$-10.86 Million ≈ $-7.68 Million |
-0.081x | -35.51% |
| 2006-12-31 | AU$135.47 Million ≈ $95.86 Million |
AU$-8.12 Million ≈ $-5.74 Million |
-0.060x | -73.92% |
| 2005-12-31 | AU$132.14 Million ≈ $93.50 Million |
AU$-4.55 Million ≈ $-3.22 Million |
-0.034x | -187.04% |
| 2004-12-31 | AU$113.22 Million ≈ $80.11 Million |
AU$-1.36 Million ≈ $-961.27K |
-0.012x | +57.60% |
| 2003-12-31 | AU$29.38 Million ≈ $20.79 Million |
AU$-831.60K ≈ $-588.41K |
-0.028x | +53.36% |
| 2002-12-31 | AU$14.81 Million ≈ $10.48 Million |
AU$-898.56K ≈ $-635.79K |
-0.061x | -18.47% |
| 2001-12-31 | AU$18.34 Million ≈ $12.98 Million |
AU$-939.40K ≈ $-664.68K |
-0.051x | -29.20% |
| 2000-12-31 | AU$20.67 Million ≈ $14.63 Million |
AU$-819.60K ≈ $-579.92K |
-0.040x | +41.04% |
| 1999-12-31 | AU$5.02 Million ≈ $3.55 Million |
AU$-337.79K ≈ $-239.01K |
-0.067x | +73.74% |
| 1998-12-31 | AU$1.59 Million ≈ $1.12 Million |
AU$-406.45K ≈ $-287.59K |
-0.256x | +63.11% |
| 1997-12-31 | AU$5.45 Million ≈ $3.86 Million |
AU$-3.78 Million ≈ $-2.68 Million |
-0.694x | -540.59% |
| 1996-12-31 | AU$27.18 Million ≈ $19.23 Million |
AU$-2.94 Million ≈ $-2.08 Million |
-0.108x | -118.58% |
| 1995-12-31 | AU$28.90 Million ≈ $20.45 Million |
AU$-1.43 Million ≈ $-1.01 Million |
-0.050x | +56.02% |
| 1994-12-31 | AU$10.81 Million ≈ $7.65 Million |
AU$-1.22 Million ≈ $-862.52K |
-0.113x | -5205.41% |
| 1993-12-31 | AU$10.42 Million ≈ $7.37 Million |
AU$23.00K ≈ $16.27K |
0.002x | -- |
About Avecho Biotechnology Ltd
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic f… Read more